3FriedenIJ, Hajistrom AN, Drolet BA,et al.Infantilehemangiomas: Current knowledge, fiiture directions.Proceedings of a research workshop on infantilehemangiomas, April7-9,2005,Bethesda,Maryland,USA [J].Pediatr Dermatol,2005,22(5):383-406.
4AbhyankarA,Jenney M,Huddart SN,et al.Use of a tissueexpander and a Polyglactic acid (Vicryl)mesh to reduceradiation enteritis:case report and literature review[J].PediatrSurg Int,2005,21(9):755-757.
5Salminen P, Vuola P, Overmark M, et al. Treatment of hemangio- mas [ J ]. Duodecim ,2012,128 ( 17 ) : 1786 - 1796.
6Winter H, Drager E, Sterry W. Sclerotherapy for treatment of he- mangiomas [ J ]. Dermatol Surg,2000,26 ( 2 ) : 105 - 108.
8Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of cortico- steroid injections and other injections for management of tendinopa- thy:a systematic review of randomized controlled rials [ J ]. Lancet, 2010,20(376) :1751 - 1767.
9Geslin JM, Benabes B, Rodor F, et al. Allergic respiratory disorders and vein sclerosis with lauromacrogol 400 [ J]. Therapie ,200d ,59 (6) :651 -653.
10Breu FX, Guggenbichler S, Wollmann JC. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Con- sensus Meeting on Foam Sclerotherapy 2006, Tegemsee, Germany [J]. Vasa,2008,37( 1 ) :90 -95.
